Publication: Responsabilidad social en un contexto de globalización de los mercados: estudio comparado de la articulación de políticas públicas en el sector farmacéutico de Brasil y España
Loading...
Files
Official URL
Full text at PDC
Publication Date
2018-10-16
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Complutense de Madrid
Citations
Exportar
Abstract
La sociedad capitalista afronta uno de sus mayores desafíos en este inicio de milenio:¿Cómo compatibilizar el desarrollo sostenible social, económico y ambiental con las fuerzas del capitalismo de eficiencia y de generación de beneficios económicos? En un contexto de creciente integración internacional y de presión de los mercados financieros, característicos del modelo de poder neoliberal, cabe preguntarse hasta qué punto las corporaciones pueden hacer elecciones verdaderamente libres, en el sentido dela construcción de un mundo más responsable. En este mismo sentido, es pertinente cuestionarse si es posible esperar o incluso demandar de los Estados y de las instituciones de gobierno una mayor participación e intervención en la sociedad en un contexto de creciente limitación presupuestaria y de pérdida de autonomía. A partir de estas inquietudes sobre el papel de las corporaciones y la validez de los conceptos de RSC y sostenibilidad esta investigación ha tenido como objetivo evaluar las prácticas corporativas, teniendo como referencia el sector farmacéutico a través del estudio de los indicadores socio ambiental y de la influencia del marco institucional de los sistemas nacionales, así como los estudios de caso de la actuación de dos corporaciones del sector en los marcos institucionales de Brasil y España. La integración real de los tres pilares del desarrollo sostenible en el sector farmacéutico ha sido contrastada empíricamente a partir del desarrollo teórico que posiciona lo público como variable crucial...
Capitalist society faces one of its greatest challenges in the beginning of themillennium: How can sustainable social, economic and environmental development bereconciled with capitalist drivers of efficiency and generation of profits? Withincreasing international integration and pressure from financial markets, typical of thecurrent neoliberal power model, it calls into question the extent to which corporationscan make elections truly free in order to build a more responsible world. Furthermore, itis worth questioning whether it is possible to demand or even expect that states andgovernmental institutions participate and intervene more in society with increasingbudgetary constraints and loss of autonomy. Based on these concerns about the role ofcorporations and about the validity of the concepts of corporate social responsibility andsustainability, this research aimed to evaluate CSR practices by using thepharmaceutical sector as an empirical reference and analysing social and environmentalperformance indicators, the influence of the institutional framework of national systemsand strategic execution case studies of two pharmaceutical corporations within theinstitutional frameworks of Brazil and Spain. The real integration of the three pillars ofsustainable development into the pharmaceutical sector was empirically tested from thestandpoint of theoretical development, which positions public interests as a crucialvariable. Organizations were assessed in terms of how public interests, represented byaccess to good public healthcare, are present in corporate governance rules of reasoningand decision-making in contrast to private interests. The study demonstrated theimportance of legal and regulatory frameworks by conditioning and limiting decisionmakingabout access to medicine, which foster or undermine responsible behavior byorganizations..
Capitalist society faces one of its greatest challenges in the beginning of themillennium: How can sustainable social, economic and environmental development bereconciled with capitalist drivers of efficiency and generation of profits? Withincreasing international integration and pressure from financial markets, typical of thecurrent neoliberal power model, it calls into question the extent to which corporationscan make elections truly free in order to build a more responsible world. Furthermore, itis worth questioning whether it is possible to demand or even expect that states andgovernmental institutions participate and intervene more in society with increasingbudgetary constraints and loss of autonomy. Based on these concerns about the role ofcorporations and about the validity of the concepts of corporate social responsibility andsustainability, this research aimed to evaluate CSR practices by using thepharmaceutical sector as an empirical reference and analysing social and environmentalperformance indicators, the influence of the institutional framework of national systemsand strategic execution case studies of two pharmaceutical corporations within theinstitutional frameworks of Brazil and Spain. The real integration of the three pillars ofsustainable development into the pharmaceutical sector was empirically tested from thestandpoint of theoretical development, which positions public interests as a crucialvariable. Organizations were assessed in terms of how public interests, represented byaccess to good public healthcare, are present in corporate governance rules of reasoningand decision-making in contrast to private interests. The study demonstrated theimportance of legal and regulatory frameworks by conditioning and limiting decisionmakingabout access to medicine, which foster or undermine responsible behavior byorganizations..
Description
Tesis de la Universidad Complutense de Madrid, Facultad de Ciencias Políticas y Sociología, leída el 19-05-2017